GUANG BO YANG, L,AC
Acupuncture at Champion Forest Dr, Houston, TX

License number
Texas AC00218
Category
Acupuncture
Type
Acupuncturist
Address
Address 2
13303 Champion Forest Dr STE 10, Houston, TX 77069
20815 Deauville Dr, Spring, TX 77388
Phone
(281) 583-5898
(281) 895-7676 (Fax)
(281) 528-6276

Personal information

See more information about GUANG BO YANG at radaris.com
Name
Address
Phone
Guang Yang
5515 Indigo St, Houston, TX 77096
Guang Yang
4018 Broken Elm Dr, Spring, TX 77388
(281) 814-4883
Guang Yang, age 55
17322 Canton Frst, Richmond, TX 77407
Guang Yang
2110 Wilcrest Dr, Houston, TX 77042
Guang Yang
4336 Darsey St, Bellaire, TX 77401

Professional information

See more information about GUANG BO YANG at trustoria.com
Guang Yang Photo 1
Ph.d. Candidate For Operations Research At Uc Berkeley

Ph.d. Candidate For Operations Research At Uc Berkeley

Position:
NSF, Research Experience for Undergraduates at Rice University
Location:
Berkeley, California
Industry:
Mechanical or Industrial Engineering
Work:
Rice University - Houston, TX since Aug 2012 - NSF, Research Experience for Undergraduates Rice University - Houston, TX May 2012 - Jul 2012 - NSF, VIGRE Internship Pomona College - Claremont, CA May 2011 - Jul 2011 - NSF, Research Experience for Undergraduates National Institute for Mathematical and Biological Synthesis (NIMBioS) - Knoxville, TN May 2010 - Jul 2010 - NSF, Research Experience for Undergraduates
Education:
University of California, Berkeley 2013 - 2018
Candidate for Ph.D. in Industrial Engineering & Operations Research, College of Engineering
Rice University 2011 - 2013
B.A. in Computational and Applied Mathematics, George R. Brown School of Engineering
Appalachian State University 2009 - 2011
Completed Courses in Mathematics and Actuarial Science, College of Arts and Sciences


Guang B Yang Photo 2
Guang B Yang, Houston TX - AC

Guang B Yang, Houston TX - AC

Specialties:
Acupuncture, Homeopathy
Address:
13303 Champion Forest Dr SUITE 10, Houston 77069
(281) 583-5898 (Phone), (281) 895-7676 (Fax)
Languages:
English


Guang Yang Photo 3
Use Of .Alpha..sub.1 -Adrenoreceptor Antagonists In The Prevention And Treatment Of Cancer

Use Of .Alpha..sub.1 -Adrenoreceptor Antagonists In The Prevention And Treatment Of Cancer

US Patent:
5935962, Aug 10, 1999
Filed:
Mar 27, 1997
Appl. No.:
8/827137
Inventors:
Timothy C. Thompson - Houston TX
Guang Yang - Houston TX
Michael G. Wyllie - New York NY
Assignee:
Baylor College of Medicine and Pfizer, Inc.
International Classification:
A61K 3150
US Classification:
514254
Abstract:
A method for treating or preventing a cancer in a mammal which comprises administering to said mammal an amount of a drug, comprising an. alpha. sub. 1 -adrenoreceptor antagonist or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing the cancer.


Guang Yang Photo 4
Use Of .Alpha.1-Adrenoreceptor Antagonists In The Prevention And Treatment Of Benign Prostatic Hyperplasia

Use Of .Alpha.1-Adrenoreceptor Antagonists In The Prevention And Treatment Of Benign Prostatic Hyperplasia

US Patent:
6177430, Jan 23, 2001
Filed:
Oct 12, 1999
Appl. No.:
9/415671
Inventors:
Timothy C Thompson - Houston TX
Guang Yang - Houston TX
Michael G Wyllie - New York NY
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 31496, A61K 31517
US Classification:
51425217
Abstract:
A method for reducing the extent of or preventing further hyperplasia in BPH in a mammal which comprises administering to said mammal an effective amount of a drug comprising an. alpha. sub. 1 -adrenoreceptor antagonist or pharmaceutically acceptable acid addition salt thereof.


Guang Yang Photo 5
Use Of Alpha1-Adrenoreceptor Antagonists In The Prevention And Treatment Of Benign Prostatic Hyperplasia

Use Of Alpha1-Adrenoreceptor Antagonists In The Prevention And Treatment Of Benign Prostatic Hyperplasia

US Patent:
2003012, Jul 3, 2003
Filed:
Feb 18, 2003
Appl. No.:
10/368676
Inventors:
Timothy Thompson - Houston TX, US
Guang Yang - Houston TX, US
Michael Wyllie - New York NY, US
Assignee:
Pfizer Inc.
International Classification:
A61K031/517
US Classification:
514/252170
Abstract:
A method for treating or preventing a BPH in a mammal which comprises administering to said mammal an amount of a drug, comprising an -adrenoreceptor antagonist or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing the BPH.